Allure Clinical 6000 – Ultra-High Potency 6000mg CBD Oil Neuro-Modulating Matrix (30 mL)

Experience Ultimate Neural Support with Allure Clinical 6000

Take control of your recovery protocol with the Allure Clinical 6000mg Neuro-Modulating Matrix, an ultra-concentrated sublingual tincture engineered for profound physiological intervention. Delivering a massive 200 mg/mL concentration of active cannabidiol per single dropper (6000 mg total per 30 mL bottle), this therapeutic-grade stabilizer acts as a powerful neurological anchor to help modulate overactive neural firing and systemic discomfort.

Formulated in an organic Coconut Medium-Chain Triglyceride (MCT) oil carrier and infused with a refreshing natural mint flavor, Allure Clinical 6000 optimizes cellular transport and sublingual absorption. By bypassing hepatic first-pass metabolism, this lipid delivery vehicle delivers rapid onset within 15 to 30 minutes, ensuring maximum plasma exposure for severe symptom management.

Designed for experienced users, clinical post-care protocols, and individuals seeking maximum receptor saturation when standard strengths fall short.

Key Features & Product Highlights

• Ultra-High Potency Matrix: Contains 6000 mg of therapeutic-grade CBD, yielding an unmatched 200 mg/mL baseline.
• Enhanced MCT Absorption: Coconut-derived MCT oil carrier provides an optimal lipid vehicle for maximum lipophilic dissolution and fast sublingual uptake.
• Natural Mint Flavor: Formulated with natural mint to enhance palatability and support the recommended 30–60 second sublingual holding period.
• Third-Party Lab Verified: Complete batch transparency via QR-coded Certificate of Analysis (COA) testing to confirm 0.00% THC, heavy metal safety, and chemical purity.
• Precision Micro-Dosing: Features a calibrated 1.0 mL dropper for precise dosage control, ideal for starting small and titrating upward.

Suggested Dosing & Usage Guide

Administer sublingually by holding drops beneath the tongue for 30 to 60 seconds before swallowing. New users should initiate therapy at a fraction of a dose and titrate upward as needed.